Literature DB >> 19670908

Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL.

Yong Yao1, Andrey A Bobkov, Leigh A Plesniak, Francesca M Marassi.   

Abstract

The BH3-only BCL-2 family protein BID is activated by caspase-8 cleavage upon engagement of cell surface death receptors. The resulting 15 kDa C-terminal fragment, tBID, translocates to mitochondria, triggering the release of cytotoxic molecules and cell death. The pro-apoptotic activity of tBID is regulated by its interactions with pro-survival BCL-XL and pro-death BAX, both in the cytosol and at the mitochondrial membrane. In this study, we characterize the molecular interactions between full-length tBID and BCL-XL using NMR spectroscopy and isothermal titration calorimetry (ITC). In aqueous solution, tBID adopts an alpha-helical but dynamically disordered conformation; however, the three-dimensional conformation is stabilized when tBID engages its BH3 domain in the BH3-binding hydrophobic groove of BCL-XL to form a stable heterodimeric complex. Characterization of the binding thermodynamics by ITC reveals that the interaction between tBID and BCL-XL is driven by enthalpy but disfavored by the entropy associated with the conformational order induced in tBID upon binding BCL-XL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19670908      PMCID: PMC2762941          DOI: 10.1021/bi901171n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane.

Authors:  R Eskes; S Desagher; B Antonsson; J C Martinou
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

3.  Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis.

Authors:  J Zha; S Weiler; K J Oh; M C Wei; S J Korsmeyer
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

Review 4.  Insights into programmed cell death through structural biology.

Authors:  S W Fesik
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

5.  Why are "natively unfolded" proteins unstructured under physiologic conditions?

Authors:  V N Uversky; J R Gillespie; A L Fink
Journal:  Proteins       Date:  2000-11-15

Review 6.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

7.  Comparative genomics: the evolutionary history of the Bcl-2 family.

Authors:  Cecilia Lanave; Monica Santamaria; Cecilia Saccone
Journal:  Gene       Date:  2004-05-26       Impact factor: 3.688

8.  NMR studies of the anti-apoptotic protein Bcl-xL in micelles.

Authors:  J A Losonczi; E T Olejniczak; S F Betz; J E Harlan; J Mack; S W Fesik
Journal:  Biochemistry       Date:  2000-09-12       Impact factor: 3.162

9.  Structural studies of apoptosis and ion transport regulatory proteins in membranes.

Authors:  Carla M Franzin; Jungyuen Choi; Dayong Zhai; John C Reed; Francesca M Marassi
Journal:  Magn Reson Chem       Date:  2004-02       Impact factor: 2.447

10.  BAX activation is initiated at a novel interaction site.

Authors:  Evripidis Gavathiotis; Motoshi Suzuki; Marguerite L Davis; Kenneth Pitter; Gregory H Bird; Samuel G Katz; Ho-Chou Tu; Hyungjin Kim; Emily H-Y Cheng; Nico Tjandra; Loren D Walensky
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

View more
  15 in total

1.  Biophysical basis of the promiscuous binding of B-cell lymphoma protein 2 apoptotic repressor to BH3 ligands.

Authors:  Vikas Bhat; Max B Olenick; Brett J Schuchardt; David C Mikles; Caleb B McDonald; Amjad Farooq
Journal:  J Mol Recognit       Date:  2013-10       Impact factor: 2.137

2.  Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor.

Authors:  Vikas Bhat; Max B Olenick; Brett J Schuchardt; David C Mikles; Caleb B McDonald; Amjad Farooq
Journal:  Biopolymers       Date:  2014-06       Impact factor: 2.505

Review 3.  Dynamic Protein Interaction Networks and New Structural Paradigms in Signaling.

Authors:  Veronika Csizmok; Ariele Viacava Follis; Richard W Kriwacki; Julie D Forman-Kay
Journal:  Chem Rev       Date:  2016-02-29       Impact factor: 60.622

4.  Conformational States of the Cytoprotective Protein Bcl-xL.

Authors:  Pavel Ryzhov; Ye Tian; Yong Yao; Andrey A Bobkov; Wonpil Im; Francesca M Marassi
Journal:  Biophys J       Date:  2020-08-20       Impact factor: 4.033

5.  Apoptotic regulation by MCL-1 through heterodimerization.

Authors:  Qian Liu; Tudor Moldoveanu; Tara Sprules; Edna Matta-Camacho; Nura Mansur-Azzam; Kalle Gehring
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

6.  Structural insights of tBid, the caspase-8-activated Bid, and its BH3 domain.

Authors:  Yu Wang; Nico Tjandra
Journal:  J Biol Chem       Date:  2013-10-24       Impact factor: 5.157

7.  Conformation of BCL-XL upon Membrane Integration.

Authors:  Yong Yao; Lynn M Fujimoto; Nathan Hirshman; Andrey A Bobkov; Antonella Antignani; Richard J Youle; Francesca M Marassi
Journal:  J Mol Biol       Date:  2015-02-27       Impact factor: 5.469

Review 8.  Intrinsically disordered proteins in bcl-2 regulated apoptosis.

Authors:  Gilles J P Rautureau; Catherine L Day; Mark G Hinds
Journal:  Int J Mol Sci       Date:  2010-04-16       Impact factor: 5.923

9.  Lipoprotein Particle Formation by Proapoptotic tBid.

Authors:  Vindana Ekanayake; Danielle Nisan; Pavel Ryzhov; Yong Yao; Francesca M Marassi
Journal:  Biophys J       Date:  2018-06-26       Impact factor: 4.033

10.  BAX and BAK caught in the act.

Authors:  Yong Yao; Francesca M Marassi
Journal:  Mol Cell       Date:  2009-11-13       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.